INCONTESTABLE® Blog
April 19, 2024
Webinar
Advertising Self-Regulation in 2024: Q&A with NAD Vice President Laura Brett
January 30, 2024
Never miss an Insight.
Sign upEvent
Discovery in U.S. Patent Litigation & Managing its Potential Impact in Related Foreign Cases Discovery in U.S. Patent Litigation & Managing its Potential Impact in Related Foreign Cases
January 18, 2023
Webinar
Event
A Fresh Look at Chemical and Pharmaceutical Selection Inventions: U.S. and European Perspectives A Fresh Look at Chemical and Pharmaceutical Selection Inventions: U.S. and European Perspectives
December 20, 2022
Webinar
Event
ABA’s Business Law Section Hybrid Spring Meeting 2022 ABA’s Business Law Section Hybrid Spring Meeting 2022
March 31-April 2, 2022
Atlanta
Event
Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
February 16, 2022
Webinar
Event
Recent IP Court Decisions Relevant to International Businesses Recent IP Court Decisions Relevant to International Businesses
October 1, 2021
Virtual
Event
American Chemical Society’s Resilience of Chemistry Conference American Chemical Society’s Resilience of Chemistry Conference
August 22-26, 2021
Atlanta
Event
Hatch-Waxman Litigation and 30-Month Stays: Multiple Stays, Late-Listed Patents, and More Hatch-Waxman Litigation and 30-Month Stays: Multiple Stays, Late-Listed Patents, and More
October 29, 2020
Webinar
Event
Patent Exclusivity Health Checks for Small Molecules: Are Your U.S. Patents Ready to Maximize ROI? Patent Exclusivity Health Checks for Small Molecules: Are Your U.S. Patents Ready to Maximize ROI?
August 11, 2020
Webinar
IP Health Blog
FDA Final Guidance on Competitive Generic Therapies FDA Final Guidance on Competitive Generic Therapies
March 25, 2020
IP Health Blog
FDA Guidance on Safety Testing of Drug Metabolites FDA Guidance on Safety Testing of Drug Metabolites
March 18, 2020
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.